产品中心
当前位置:首页
产品中心
抗体/抗原
Biosimilar抗体
S0B1436Anti-human Claudin 18.2 Monoclonal Antibody (zolbetuximab)
产品型号:S0B1436
更新时间:2025-08-10
厂商性质:生产厂家
访问量:92
15855403091
Claudin 18.2 monoclonal antibodies are a promising class of therapeutic agents targeting the Claudin 18.2 protein, a tight junction protein that is highly expressed in various cancers, including gastric, pancreatic, and ovarian cancers. In normal tissues, Claudin 18.2 is predominantly expressed in differentiated gastric mucosal cells, but its upregulation in tumor cells makes it an attractive target for cancer therapy. These monoclonal antibodies, such as Zolbetuximab, work by binding specifically to the extracellular domain of Claudin 18.2, inducing antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) to kill cancer cells.